Explore All Access
Check if your research matches the topics covered in Nucleic Acid Therapeutics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Nucleic Acid Therapeutics : Impact Factor & More
eISSN: 2159-3345pISSN: 2159-3337
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Nucleic Acid Therapeutics Key Metrics
CiteScore 
9.3
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Genetics
SNIP
1.19
Topics Covered on Nucleic Acid Therapeutics
Oligonucleotide
RNA interference
RNA editing
Guide RNA
Exon
Amyloid precursor protein
Antisense oligonucleotides
Minicircle dna
Serum protein
Duchenne muscular dystrophy
Exon skipping
DNA Aptamers
Antisense RNA
Amyloid angiopathy
Type 2 diabetes
Protein splicing
G-quadruplex
RNA Aptamers
Ribosomal protein
Nucleic Acid Therapeutics Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Nucleic Acid Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Nucleic Acid Therapeutics
Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells.
- 1 Oct 2024
- Nucleic acid therapeutics
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Nucleic Acid Therapeutics.
- 1 Oct 2024
- Nucleic acid therapeutics
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations.
- 23 Sep 2024
- Nucleic acid therapeutics
An Evaluation of First-in-Human Studies for RNA Oligonucleotides
- 23 Sep 2024
- Nucleic Acid Therapeutics
Near Sequence Homology Does Not Guarantee siRNA Cross-Species Efficacy.
- 27 Aug 2024
- Nucleic acid therapeutics
Mass Spectrometry as a Quantitative Tool for SpCas9 sgRNA Quality Control.
- 23 Aug 2024
- Nucleic acid therapeutics
Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells.
- 1 Oct 2024
- Nucleic acid therapeutics
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Nucleic Acid Therapeutics.
- 1 Oct 2024
- Nucleic acid therapeutics
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations.
- 23 Sep 2024
- Nucleic acid therapeutics
An Evaluation of First-in-Human Studies for RNA Oligonucleotides
- 23 Sep 2024
- Nucleic Acid Therapeutics
Near Sequence Homology Does Not Guarantee siRNA Cross-Species Efficacy.
- 27 Aug 2024
- Nucleic acid therapeutics
Mass Spectrometry as a Quantitative Tool for SpCas9 sgRNA Quality Control.
- 23 Aug 2024
- Nucleic acid therapeutics
Compare Similar Journals with Nucleic Acid Therapeutics
Select Journals to Compare with Nucleic Acid Therapeutics
Total journals - 8
You can select up to 3 Journals at a time
International Journal of Molecular Sciences
Publisher: MDPI
Nucleic Acids Research
Publisher: OXFORD UNIV PRESS
Scientific Reports
Publisher: NATURE PORTFOLIO
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Molecular Therapy - Nucleic Acids
Publisher: CELL PRESS
Molecules
Publisher: MDPI
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Controlled Release
Publisher: ELSEVIER
0 Journals Selected to compare with
Nucleic Acid Therapeutics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Nucleic Acid Therapeutics
How long has Nucleic Acid Therapeutics been actively publishing? 
Nucleic Acid Therapeutics has been in operation since 2011 till date.
What is the publishing frequency of Nucleic Acid Therapeutics?
Nucleic Acid Therapeutics published with a Bi-monthly frequency.
How many articles did Nucleic Acid Therapeutics publish last year?
In 2023, Nucleic Acid Therapeutics publsihed 26 articles.
What is the eISSN & pISSN for Nucleic Acid Therapeutics?
For Nucleic Acid Therapeutics, eISSN is 2159-3345 and pISSN is 2159-3337.
What is Citescore for Nucleic Acid Therapeutics?
Citescore for Nucleic Acid Therapeutics is 9.3.
What is SNIP score for Nucleic Acid Therapeutics?
SNIP score for Nucleic Acid Therapeutics is 1.19.
What is the SJR for Nucleic Acid Therapeutics?
SJR for Nucleic Acid Therapeutics is Q1.
Who is the publisher of Nucleic Acid Therapeutics?
MARY ANN LIEBERT, INC is the publisher of Nucleic Acid Therapeutics.
